Redmile Group, LLC

Redmile Group, LLC is listed in filings as Director, 10% Owner at Shattuck Labs, Inc.. This profile follows SEC Form 4 activity through Apr 23, 2026, including sale activity and purchase activity. Recent filings connect the profile to Shattuck Labs, Inc. (STTK), IGM Biosciences, Inc. (IGMS), FATE THERAPEUTICS INC (FATE), and Augmedix, Inc. (AUGX). The current snapshot covers public activity from Jun 14, 2024 to Apr 23, 2026. Reported amounts are shown as $121.0K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.